Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020579 |
---|---|
Receipt number | R000023554 |
Scientific Title | An open label, non-randomized phase I/II study of ramucirumab in combination with nab-paclitaxel as second-line therapy in patients with advanced gastric cancer |
Date of disclosure of the study information | 2016/01/15 |
Last modified on | 2019/07/22 19:35:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/01/15 11:58:10 | ||
2 | Update | 2018/07/18 19:09:26 | Name of primary person or sponsor Organization |
|
3 | Update | 2018/07/18 19:11:03 | Date of closure to data entry |
|
4 | Update | 2019/07/22 19:35:44 | Recruitment status Date of IRB Last follow-up date |